Cashu
CytomX Therapeutics Faces Mixed Analyst Ratings Amid Clinical Developments and Market Competition
4 days ago
Stocks
Health Care
ctmx
CytomX Therapeutics
NASDAQ: CTMX
+2.07 (+44.12%)
6.745
USD
At close at Mar 16, 20:40 UTC
Latest CytomX Therapeutics News
benzinga.com
Mid-Cap CytomX Therapeutics' Colorectal Cancer Data Fuels Stock Rally
about 5 hours ago
benzinga.com
Nebius Group, CytomX Therapeutics, National Storage Affiliates Trust And Other Big Stocks Moving Higher On Monday
about 7 hours ago
benzinga.com
Earnings Scheduled For March 16, 2026
about 10 hours ago
benzinga.com
Where CytomX Therapeutics Stands With Analysts
7 days ago
benzinga.com
Earnings Scheduled For November 6, 2025
4 months ago
benzinga.com
CytomX Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
5 months ago
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
6 months ago
benzinga.com
Intuit, Workday And Other Big Stocks Moving Lower In Friday's Pre-Market Session
7 months ago
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
7 months ago
benzinga.com
Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesday
10 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.